127 related articles for article (PubMed ID: 30654843)
1. Ell3 functions as a critical decision maker at the crossroad between stem cell senescence and apoptosis.
Lee JY; Lee SH; Kim KS; Park KH; Park KS
Stem Cell Res Ther; 2019 Jan; 10(1):32. PubMed ID: 30654843
[TBL] [Abstract][Full Text] [Related]
2. Ell3 enhances differentiation of mouse embryonic stem cells by regulating epithelial-mesenchymal transition and apoptosis.
Ahn HJ; Cha Y; Moon SH; Jung JE; Park KS
PLoS One; 2012; 7(6):e40293. PubMed ID: 22768269
[TBL] [Abstract][Full Text] [Related]
3. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
4. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
[TBL] [Abstract][Full Text] [Related]
5. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.
Lin C; Garruss AS; Luo Z; Guo F; Shilatifard A
Cell; 2013 Jan; 152(1-2):144-56. PubMed ID: 23273992
[TBL] [Abstract][Full Text] [Related]
6. Ell3 stimulates 5-FU resistance in a breast cancer cell line.
Kim I; Kim KS; Kwon OS; Cha HJ; Park KS
Oncol Lett; 2017 Jun; 13(6):4173-4179. PubMed ID: 28588704
[TBL] [Abstract][Full Text] [Related]
7. Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression.
Chen WS; Yu YC; Lee YJ; Chen JH; Hsu HY; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):566-74. PubMed ID: 20457353
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
9. Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro.
Ma Y; Wang Y; Song B
Breast Cancer; 2019 Mar; 26(2):190-197. PubMed ID: 30259331
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis and cellular senescence in mice lacking transcription elongation factor, Elongin A.
Miyata K; Yasukawa T; Fukuda M; Takeuchi T; Yamazaki K; Sakumi K; Tamamori-Adachi M; Ohnishi Y; Ohtsuki Y; Nakabeppu Y; Kitajima S; Onishi S; Aso T
Cell Death Differ; 2007 Apr; 14(4):716-26. PubMed ID: 17170753
[TBL] [Abstract][Full Text] [Related]
11. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
Lee JY; Park YJ; Oh N; Kwack KB; Park KS
Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
[TBL] [Abstract][Full Text] [Related]
12. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism.
Kim KS; Seu YB; Baek SH; Kim MJ; Kim KJ; Kim JH; Kim JR
Mol Biol Cell; 2007 Nov; 18(11):4543-52. PubMed ID: 17804819
[TBL] [Abstract][Full Text] [Related]
13. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW
Cell; 2002 May; 109(3):335-46. PubMed ID: 12015983
[TBL] [Abstract][Full Text] [Related]
14. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
[TBL] [Abstract][Full Text] [Related]
15. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
Ong ALC; Ramasamy TS
Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
[TBL] [Abstract][Full Text] [Related]
16. B1-induced caspase-independent apoptosis in MCF-7 cells is mediated by down-regulation of Bcl-2 via p53 binding to P2 promoter TATA box.
Liang X; Xu K; Xu Y; Liu J; Qian X
Toxicol Appl Pharmacol; 2011 Oct; 256(1):52-61. PubMed ID: 21821060
[TBL] [Abstract][Full Text] [Related]
17. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
[TBL] [Abstract][Full Text] [Related]
18. The tissue dependent interactions between p53 and Bcl-2 in vivo.
Li X; Miao X; Wang H; Xu Z; Li B
Oncotarget; 2015 Nov; 6(34):35699-709. PubMed ID: 26452131
[TBL] [Abstract][Full Text] [Related]
19. Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments.
Cmielova J; Havelek R; Soukup T; Jiroutová A; Visek B; Suchánek J; Vavrova J; Mokry J; Muthna D; Bruckova L; Filip S; English D; Rezacova M
Int J Radiat Biol; 2012 May; 88(5):393-404. PubMed ID: 22348537
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
